FCBR425QB1C07 Bei (USD) [123pcs Hisa]
- 1 pcs$372.72598
- Nambari ya Sehemu:
- FCBR425QB1C07
- Mzalishaji:
- Finisar Corporation
- Maelezo ya kina:
- CABLE OPT 4X25G INFINIBAND QSFP. Fiber Optic Cable Assemblies 4x25G, full-duplex, INFINIBAND, QSFP cable ends, electrical limiting interface, RoHS, multimode, 0/70 C operation. Internal optics: 850nm VCSEL array, PIN array, round ris
- Manufacturer's standard lead time:
- Katika hisa
- Maisha ya rafu:
- Mwaka mmoja
- Chip Kutoka:
- Hong Kong
- RoHS:
- Njia ya malipo:
-
- Njia ya usafirishaji:
- Jamii Jamii:
- VITAMBUZI VYA Co, LTD ni Msambazaji wa Vipengele vya Elektroniki ambavyo hutoa aina za bidhaa pamoja na: Nguvu, Bodi za Mia na kamba za Upanuzi, Mabati ya Flat Flex (FFC, FPC), Makanisa ya Cable Maalum, Mabango ya Taa za Jimbo Mango, Mabango ya Firewire (IEEE 1394), Waya za jumper, inaongoza kabla, Karatasi za Optic za nyuzi and Mabango ya kawaida ...
- Faida ya Ushindani:
- We specialize in Finisar Corporation FCBR425QB1C07 electronic components. FCBR425QB1C07 can be shipped within 24 hours after order. If you have any demands for FCBR425QB1C07, Please submit a Request for Quotation here or send us an email: rfq@key-components.com
FCBR425QB1C07 Sifa za Bidhaa
Nambari ya Sehemu :
FCBR425QB1C07
Mzalishaji :
Finisar Corporation
Maelezo :
CABLE OPT 4X25G INFINIBAND QSFP
Mfululizo :
-
Hali ya Sehemu :
Not For New Designs
Viunga vya Cable :
-
Idadi ya Nafasi :
-
Aina ya kiunganishi :
-
Jinsia :
-
Aina ya kufunga :
-
Vipengele :
-
Aina ya Cable :
-
Matumizi :
-
Urefu :
-
Rangi :
-
Kuvimba :
-
Habari mpya kabisa
Unaweza pia Kuvutiwa Na
-
-
-
-
FCCN410QD3CX0
Finisar Corporation
CABLE QSFP M-M 100M. Fiber Optic Cable Assemblies Fiber Optic Cable Assemblies
-
FCBN425QB1C03
Finisar Corporation
CABLE QSFP28 M-M 3M. Fiber Optic Cable Assemblies 100G QSFP28 QSFP AOC
-
FCBN425QB1C05
Finisar Corporation
CABLE QSFP28 M-M 5M. Fiber Optic Cable Assemblies 100G QSFP28 QSFP AOC
Sehemu za Moto
- 1110403305
- FCBN425QB1C25
- 6A44-B0441-040.0-0
- FCBG414QB1C15
- 6A11-A0121-070.0-0
- 6A44-B0421-023.0-0
- 1003461151
- ICD040GVP163D-03
- 6A22-D0421-029.0-0
- ICD056GVP163D-14
- FCF8-10-01-L-19.68-S
- 10128238-4SR3232LF
- 0747521208
- 6A44-B0441-022.0-0
- 0745472064
- 2123909-4
- 6A25-A0421-020.0-0
- 6A11-A0141-030.0-0
- 0745470104
- ICD150GVP245H-10
- 0685610022
- 10126226-B02002JLF
- 10007290-P0050CULF
- 0745470001
- 10110818-2030LF
- 6A22-A0441-070.0-0
- 1110402304
- 6A22-A0441-029.0-0
- 10136283-10
- 10007290-R0500CULF
- ICD056GVP163D-15
- 0739391006
- 0745472001
- 0745581001
- 1110251208
- 1110251207
- 6A24-B0421-029.0-0
- QLX4000CQSFP1028
- 10111728-15S115HLF
- 10115005-7SR140HLF